PMID: 3761519Oct 24, 1986Paper

Improved cognition after control of risk factors for multi-infarct dementia

JAMA : the Journal of the American Medical Association
J S MeyerK F Mortel

Abstract

A cohort of 52 patients (30 men and 22 women) with multi-infarct dementia (MID) has been followed up prospectively for a mean interval of 22.2 months. Clinical course has been documented by serial history taking and interviews and neurological, medical, and psychological examinations, and correlated with measurements of cerebral blood flow. The clinical course and cognitive performance have been compared with those of age-matched normal volunteers and patients with Alzheimer's disease. Patients with MID were subdivided into hypertensive and normotensive groups, and also into those displaying stabilized or improved cognition and those whose condition deteriorated. Among hypertensive patients with MID, improved cognition and clinical course correlated with control of systolic blood pressure within upper limits of normal (135 to 150 mm Hg), but if systolic blood pressure was reduced below this level, patients with MID deteriorated. Among normotensive patients with MID, improved cognition was associated with cessation of smoking cigarettes.

Citations

May 1, 1991·Postgraduate Medical Journal·P DiggoryC Weinstein
Jan 7, 1989·BMJ : British Medical Journal·R Ramsay, C L Katona
Mar 4, 1989·BMJ : British Medical Journal·A M Clarfield
Dec 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·J S MeyerK F Mortel
Dec 15, 2010·Stroke; a Journal of Cerebral Circulation·Randolph S Marshall, Ronald M Lazar
May 11, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Deborah A Levine, Kenneth M Langa
Apr 3, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·A S Rigaud, B Forette
Aug 8, 2002·Journal of the American Geriatrics Society·Dina ZekryGabriel Gold
Jul 3, 2002·Aging Clinical and Experimental Research·Arkadiusz Siennicki-LantzSölve Elmståhl
Dec 20, 2007·American Journal of Therapeutics·Antonio CherubiniUmberto Senin
Apr 23, 2003·Cardiology in Review·Jesse WeinbergerDawn Terashita
Mar 7, 2003·Alzheimer Disease and Associated Disorders·Betty Smith BlackPeter V Rabins
Jan 1, 1997·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·I Skoog
Jan 1, 1997·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Z GuoB Winblad
Jan 18, 2002·Current Opinion in Neurology·Hans-Peter Haring
Dec 16, 1998·Journal of the Neurological Sciences·K A Jellinger
Aug 7, 2002·Journal of the Neurological Sciences·John MeyerMinh Quach
May 1, 1994·Journal of the Neurological Sciences·J S MeyerS Weathers
Jul 24, 2001·International Journal of Geriatric Psychiatry·Y S LiJ Thornby
May 29, 2001·International Journal of Geriatric Psychiatry·Y LiJ Thornby
Mar 2, 2010·Disease-a-month : DM·Antonio CherubiniUmberto Senin
May 6, 2008·Clinical Neurology and Neurosurgery·Vincent C MokLawrence Wong
Jan 3, 2013·International Journal of Stroke : Official Journal of the International Stroke Society·Toby B CummingRonald M Lazar
May 27, 2003·International Journal of Geriatric Psychiatry·M E Devine, G Rands
Mar 31, 2004·Journal of Cataract and Refractive Surgery·Hiroki TamuraHiromu K Mishima
Jun 1, 1989·Journal of the American Geriatrics Society·R D Cebul
Jun 1, 1989·Journal of the American Geriatrics Society·J S MeyerJ Lotfi
Jul 1, 2005·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Olivier Hanon, Françoise Forette
Oct 18, 2012·Annals of Medicine·Timo E StrandbergTimo J Erkinjuntti
Jul 1, 1992·Journal of the American Geriatrics Society·P V Rabins
Dec 1, 1989·Journal of the American Geriatrics Society·J A RhymesC K Cassel
Mar 1, 1996·Journal of the American Geriatrics Society·L FerrucciR J Havlik
Mar 1, 1996·Journal of the American Geriatrics Society·L White
Apr 1, 1996·Journal of the American Geriatrics Society·J M StarrI J Deary
Jul 1, 1996·Journal of the American Geriatrics Society·L H Kuller
Sep 1, 1997·Journal of the American Geriatrics Society·R Kandel
Nov 11, 1998·Journal of the American Geriatrics Society·D L Nyenhuis, P B Gorelick
Mar 1, 1997·Journal of the American Geriatrics Society·T H Goldberg, S I Chavin
Jan 1, 1987·International Journal of Psychiatry in Medicine·L A HersheyS L Yang
Dec 1, 1991·The Australian and New Zealand Journal of Psychiatry·B Draper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.